Vimarsana
Biggest News Aggregation in the World

Page 13 - Gen Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gen Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gen Li Today - Breaking & Trending Today

Major purge in China's nuclear arsenal command; Xi consolidating power and eliminating corruption? - Vimarsana News

Major purge in China's nuclear arsenal command; Xi consolidating power and eliminating corruption?

Continuing with recent changes Beijing has replaced two leaders of an elite unit managing its nuclear arsenal, triggering speculation of a purge. General Li Yuchao who headed the People's Liberation Army's (PLA) Rocket Force unit and his deputy had 'disappeared' for months.

Xi Jinping replaces leaders of China's elite nuclear force - Vimarsana News

Xi Jinping replaces leaders of China's elite nuclear force

China replaced two leaders of an elite unit managing its nuclear arsenal, triggering speculation of a purge. General Li Yuchao who...

Xi Jinping replaces leaders of China's elite nuclear force - Vimarsana News

Xi Jinping replaces leaders of China's elite nuclear force

China replaced two leaders of an elite unit managing its nuclear arsenal, triggering speculation of a purge. General Li Yuchao who...

China's Xi Jinping installs new Rocket Force leadership amid major purge - Vimarsana News

China's Xi Jinping installs new Rocket Force leadership amid major purge

Appointments of senior military officials from outside Rocket Force signals an effort by Xi to clean house: Experts Read more at straitstimes.com.

Depression now one of the top five most studied disease areas in clinical development, finds Phesi - Vimarsana News

Depression now one of the top five most studied disease areas in clinical development, finds Phesi

Phesi, a global provider of patient-centric data analytics, has released the results of its mid-year global analysis of all clinical trials conducted in 2023 to date.